Skip Navigation

Former Aimmune CEO talks biotech's latest therapy for food allergies

In this video

5TA-FF

Mad Money with Jim Cramer

Former Aimmune CEO talks biotech's latest therapy for food allergies

Jim Cramer sits down with former Aimmune CEO Stephen Dilly to discuss how the company is fighting the country's most prevalent food allergies.

01:00

Thu, Jun 28 20181:50 PM EDT

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

5 hours ago

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

FAA probing Boeing 787 inspections to find out if employees falsified records

FAA probing Boeing 787 inspections to find out if employees falsified records

Hightower's Stephanie Link doesn't expect a Fed cut this year

Hightower's Stephanie Link doesn't expect a Fed cut this year

Food startup uses AI to cut food waste

Food startup uses AI to cut food waste

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

5 hours ago

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

FAA probing Boeing 787 inspections to find out if employees falsified records

FAA probing Boeing 787 inspections to find out if employees falsified records

Hightower's Stephanie Link doesn't expect a Fed cut this year

Hightower's Stephanie Link doesn't expect a Fed cut this year

Food startup uses AI to cut food waste

Food startup uses AI to cut food waste